Oncology and Therapy

Aims & Scope

Oncology and Therapy is an international, peer reviewed, rapid-publication (peer review in 2 weeks, published 3–4 weeks from acceptance) journal dedicated to the publication of high-quality pre-clinical, clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of therapeutics and interventions (including devices) across all therapeutic areas.

Studies relating to diagnostics and diagnosis, pharmacoeconomics, public health, epidemiology, quality of life, and patient care, management, and education are also encouraged.

The journal is of interest to a broad audience of healthcare professionals and publishes original research, reviews, communications and letters.

The journal is read by a global audience and receives submissions from all over the world.

Oncology and Therapy will consider all scientifically sound research be it positive, confirmatory or negative data.

Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations.

This inclusive approach allows the journal to assist in the dissemination of all scientifically and ethically sound research.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Web of Science
• Embase

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 5,500.00 EUR. Learn more.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment

  Citation: 205

  Authors: Jamie, Maryam, David, Cheng, Kohei, Anne, Tony, Andrew, Bernhard, Rayaz A., Uazman

• A Review of Fulvestrant in Breast Cancer

  Citation: 159

  Authors: Mark R., Peter

• The Role of Interleukin-1 in the Pathogenesis of Cancer and its Potential as a Therapeutic Target in Clinical Practice

  Citation: 94

  Authors: Adi, Khaled, Idan

• When Tissue is an Issue the Liquid Biopsy is Nonissue: A Review

  Citation: 67

  Authors: July, Jenny, Christian, Alejandro, Alessandro, Luisa, Camila, Oscar, Zyanya Lucia, Gonzalo, Andrés F.

• Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): Advances and Treatment Strategies in the First-Line Setting

  Citation: 64

  Authors: Kenrick, Shievon, Jonathan

• Intra-Abdominal and Abdominal Wall Desmoid Fibromatosis

  Citation: 62

  Authors: J. Harrison, Raphael E.

• Uveal Melanoma: A Review of the Literature

  Citation: 59

  Authors: Manni, Priya, Jensen

• DNA Mutations May Not Be the Cause of Cancer

  Citation: 58

  Authors: Adouda

• Current Status and Study Progress of Recombinant Human Endostatin in Cancer Treatment

  Citation: 50

  Authors: Kai, Mingliang, Shukui

• Acute Promyelocytic Leukemia: A History over 60 Years—From the Most Malignant to the most Curable Form of Acute Leukemia

  Citation: 50

  Authors: Xavier